Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT

10 Mar 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Eosinophilic Disorders and Syndromes

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24614839
DOI: 10.1038/bmt.2014.35

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCTPMID 24614839Read ↗

Atypical CML with mutated SRSF2, ASXL1, CSF3R, and MPL.Semantic proximity Read ↗

De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML.Semantic proximity Read ↗

Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.Semantic proximity Read ↗

An abnormality in the cerebrospinal fluid before transplantation is predictive of poor outcomes after allotransplantation in AML patientsSemantic proximity Read ↗

Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CRSemantic proximity Read ↗

Insights into JAK2-V617F mutation in CMLSemantic proximity Read ↗

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.Semantic proximity Read ↗

Donor CSF3R with the rs3917980A/G or G/G genotype is correlated with better leukemia-free survival after allogenic hematopoietic stem cell transplantation.Semantic proximity Read ↗

FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?Semantic proximity Read ↗

CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.Semantic proximity Read ↗

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.Semantic proximity Read ↗

Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.